Exsilio Therapeutics (Series A)
Funding Details
Awarder
Inbox
Date Award
June 25, 2024
Vertical
Genomic Medicines
Funding URL
View Funding Page
Funding Amount
$82,000,000
Company Info
Founders
Tal Zaks, M.D., Ph.D.
Market
Genetic Diseases, Cancer, Autoimmune Conditions
Location
New York, NY, USA
Coinvestors
Arc Ventures, Deep Insight, Delos Capital, Innovation Endeavors, Insight Partners, Invus, Novartis Venture Funds, OrbiMed US
Company Description

Exsilio develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.

Links
WebsiteCrunchbaseLinkedIn
Back to HomeBack to Genomic Medicines DealsView Funding Announcement